Skinvive by Juvéderm Targets Neck Lines in New FDA Filing
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
The award recognizes over two decades of contributions to research, innovation, and education in the field of aesthetic medicine.